Costello Asset Management, INC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1760145
FEASTERVILLE, PA
Position in VRTX
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$312,443
+$49,431 QoQ
Shares Held
629
+6.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,221
of 1,745 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Costello Asset Management, INC holds $718,779 across 19 Biotechnology names. VRTX ranks #1 (43.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
629 | $312,443 | |
| 2 | BNTX |
BioNTech SE
|
1,000 | $93,050 | |
| 3 | MRNA |
Moderna, Inc.
|
900 | $63,027 | |
| 4 | EXEL |
Exelixis, Inc.
|
750 | $40,807 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
600 | $32,724 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
400 | $32,604 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
43 | $26,812 | |
| 8 | 600 | $25,500 |
All Filings in VRTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $312,443 | 629 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $263,012 | 589 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $272,469 | 601 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $230,675 | 589 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $306,742 | 689 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $322,405 | 665 | Shares | Sole | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||